AlteBio in deal with Duke University

NorthCarolina, USA-based Alte Biosciences, a drug development company, says that it has secured exclusive rights to intellectual property developed at the Duke University Medical Center for novel therapeutics targeting late-onset depression and related disorders.

The licensed technology is a patent based on findings by Ranga Krishnan on the relationship between cerebrovascular disease and the onset of depression in elderly individuals, a disease called vascular depression. Dr Krishnan is professor and chairman of the Department of Psychiatry and Behavioral Sciences at Duke University Medical Center, and a leading clinician in treating refractory depression and anxiety disorders.